Alzheimer's patients with a baseline CDR-SB score of 3.5 could expect approximately 4 additional months (95% CI 2-7 months) ...

A study reveals how a common gut bacterium may accelerate Alzheimer’s disease, reshaping medical perspectives on brain health ...

Research finds that 40 percent of dementia cases may be preventable—and healthy diets rich in polyphenols, healthy fats, and ...

Scientists have identified a biomarker for Alzheimer's that may help doctors spot the early signs of protein buildup in the ...

Alzheimer's disease (AD), the most common form of dementia, continues to remain one of modern medicine's greatest challenges.

These various tests are at different stages of validation – assuring they’re accurate across many different populations. And, for each protein, there are several different met ...

The biomarker test is a spinal tap test (also called a lumbar puncture) that uses a needle to remove cerebrospinal fluid (i.e ...

Two widely touted Alzheimer’s drugs have been shown to enable patients to remain in their homes for longer periods of time.

A new biomarker test can detect early-stage tau protein clumping up to a decade before it appears on brain scans, improving early Alzheimer’s diagnosis. Unlike amyloid-beta, tau neurofibrillary ...

Researchers at Washington University School of Medicine in St. Louis have conducted a longitudinal study on an individual ...

Scientists restore a key Alzheimer’s pathway, revealing a potential new treatment by targeting harmful oxysterol buildup.

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...